LT3618821T - Nefrogeninio necukrinio diabeto valdymas - Google Patents

Nefrogeninio necukrinio diabeto valdymas

Info

Publication number
LT3618821T
LT3618821T LTEPPCT/US2018/016184T LTUS2018016184T LT3618821T LT 3618821 T LT3618821 T LT 3618821T LT US2018016184 T LTUS2018016184 T LT US2018016184T LT 3618821 T LT3618821 T LT 3618821T
Authority
LT
Lithuania
Prior art keywords
insulication
management
nephrogenic diabetes
nephrogenic
diabetes
Prior art date
Application number
LTEPPCT/US2018/016184T
Other languages
English (en)
Inventor
Jeff SANDS
Janet KLEIN
Ish Khanna
Sivaram Pillarisetti
Original Assignee
Nephrodi Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nephrodi Therapeutics, Inc. filed Critical Nephrodi Therapeutics, Inc.
Publication of LT3618821T publication Critical patent/LT3618821T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTEPPCT/US2018/016184T 2017-01-31 2018-01-31 Nefrogeninio necukrinio diabeto valdymas LT3618821T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762452616P 2017-01-31 2017-01-31
PCT/US2018/016184 WO2018144570A1 (en) 2017-01-31 2018-01-31 Managing nephrogenic diabetes insipidus

Publications (1)

Publication Number Publication Date
LT3618821T true LT3618821T (lt) 2025-05-26

Family

ID=63040033

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/US2018/016184T LT3618821T (lt) 2017-01-31 2018-01-31 Nefrogeninio necukrinio diabeto valdymas

Country Status (14)

Country Link
US (3) US11179354B2 (lt)
EP (1) EP3618821B8 (lt)
AU (1) AU2018217038B2 (lt)
CA (1) CA3071385A1 (lt)
DK (1) DK3618821T3 (lt)
ES (1) ES3024479T3 (lt)
FI (1) FI3618821T3 (lt)
HR (1) HRP20250377T1 (lt)
HU (1) HUE071486T2 (lt)
LT (1) LT3618821T (lt)
PL (1) PL3618821T3 (lt)
PT (1) PT3618821T (lt)
SI (1) SI3618821T1 (lt)
WO (1) WO2018144570A1 (lt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9827222B2 (en) 2013-07-01 2017-11-28 Emory University Treating or preventing nephrogenic diabetes insipidus
PT3618821T (pt) 2017-01-31 2025-05-14 Nephrodi Therapeutics Inc Manejo da diabetes insípida nefrogénica
WO2022081858A1 (en) * 2020-10-14 2022-04-21 Emory University Methods of managing side effects of a vasopressin receptor antagonist therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5864381A (en) 1996-07-10 1999-01-26 Sandia Corporation Automated pupil remapping with binary optics
HUE036646T2 (hu) 2003-01-23 2018-07-30 Esperion Therapeutics Inc Hidroxilvegyületek és kompozícióik koleszterin szabályozására és kapcsolódó alkalmazásokra
US20090297497A1 (en) * 2004-10-25 2009-12-03 Kishore Bellamkonda K Methods and compositions for treating nephrogenic diabetes and insipidus
CA2812109A1 (en) * 2010-09-20 2012-03-29 Kareus Therapeutics, Sa Methods and compositions for treatment of diabetes and dyslipidemia
US20140121267A1 (en) 2011-09-20 2014-05-01 Kareus Therapeutics, Sa Methods and compositions for treatment of diabetes and dyslipidemia
US9827222B2 (en) 2013-07-01 2017-11-28 Emory University Treating or preventing nephrogenic diabetes insipidus
WO2015101609A1 (en) 2013-12-31 2015-07-09 Stichting Katholieke Universiteit Method for treating renal disorders
PT3618821T (pt) 2017-01-31 2025-05-14 Nephrodi Therapeutics Inc Manejo da diabetes insípida nefrogénica

Also Published As

Publication number Publication date
HUE071486T2 (hu) 2025-09-28
US20240139127A1 (en) 2024-05-02
EP3618821A4 (en) 2021-03-03
US20200383940A1 (en) 2020-12-10
EP3618821B1 (en) 2025-03-12
ES3024479T3 (en) 2025-06-04
SI3618821T1 (sl) 2025-07-31
DK3618821T3 (da) 2025-04-07
AU2018217038B2 (en) 2023-07-06
US12433858B2 (en) 2025-10-07
PT3618821T (pt) 2025-05-14
AU2018217038A1 (en) 2020-07-02
FI3618821T3 (fi) 2025-06-20
HRP20250377T1 (hr) 2025-07-18
US11179354B2 (en) 2021-11-23
PL3618821T3 (pl) 2025-07-07
WO2018144570A1 (en) 2018-08-09
EP3618821B8 (en) 2025-04-23
CA3071385A1 (en) 2018-08-09
US20220031639A1 (en) 2022-02-03
EP3618821A1 (en) 2020-03-11
US11844770B2 (en) 2023-12-19

Similar Documents

Publication Publication Date Title
IL256999B (en) Diabetes management therapy advisor
EP3704685A4 (en) VERTIPORTS MANAGEMENT PLATFORM
EP3578560A4 (en) QUINAZOLINE COMPOUND
EP3615661C0 (en) BI- OR MULTI-DIFFERENTIATED ORGANOID
DK3474804T4 (da) Medicinsk forbinding
EP3609871A4 (en) ARYL CYCLOPROPYL-AMINO-ISOQUINOLINYL AMIDE COMPOUNDS
EP3718392A4 (en) HARVEST MACHINE
DK3737403T5 (da) Modificerede adenovira
DK4039675T3 (da) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl forbindelser
PL3672948T3 (pl) Związki pirydynoamino-pirydonu i pirymidynoamino-pirydonu
EP3542366C0 (en) BASIC INSULIN MANAGEMENT
DK3414367T3 (da) Fosfordoteret siliciumenkeltkrystal
EP3533422C0 (en) Flat foot orthosis
EP3454846A4 (en) CRYSTALS
UA38744S (uk) Монітор
EP3734672A4 (en) PRODUCTION MANAGEMENT DEVICE
EP2976864A4 (en) RECOMMENDATIONS
HUE056928T2 (hu) Új vegyületek
DK3672941T3 (da) Pyridylpyridonforbindelser
HRP20251697T1 (hr) Kristalni oblik n-butildeoksigalaktonojirimicina
LT3618821T (lt) Nefrogeninio necukrinio diabeto valdymas
DK3672962T3 (da) Morpholinylpyridonforbindelser
DK3672967T3 (da) Azaindolylpyridon- og diazaindolylpyridonforbindelser
EP3838146A4 (en) OXYMETER
EP3838145A4 (en) OXYMETER